Bibliography
- CREMER RJ, PERRYMAN PW, RICHARDS DH: Influence of light on the hyperbilirubinaemia of infants. Lancet (1958) 1:1094–1097.
- PARRISH JA, FITZPATRICK TB, TANENBAUM L, PATHAK MA: Photochemotherapy of Psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl. J. Med. (1974) 291:1207–1222.
- DOUGHERTY TJ: Photosensitisers: Therapy and detection of tumours. Photochem. Photobiol. (1987) 45:879–889.
- DOUGHERTY TJ: Photodynamic therapy. Photochem. Photobiol. (1993) 58:895–900.
- MOAN J, BERG K, KVAN E et al.: Intracellular localiza-tion of photosensitizers. in Photosensitisinf Compounds: Their Chemistry, Biology and Clinical Use. Ciba Foundation Symp. (1989)146:95–111.
- DJH ROBERTS, F CAIRNDUFF: Photodynamic Therapy of primary skin cancer: A review. Br. J. Plastic Surg. (1995) 48:360–370
- MEYER BETZ F: Untersuchungen uber die biologische (photodynamische) wirkung des hamatoporphyrins und anderen derivate bes blut gallenfarbstoffs. Deutsch. Arch. KIM. Med. (1913) 112:476–503.
- LIPSON RL, BALDES EJ, OLSEN AM: The use of a deriva-tive of haematoporphyrin in tumour detection. J. Nati Cancer Inst. 26:1–11.
- CJ BYRNE, LV MARSHALLSAY, AD WARD: The composi-tion of Photofrin II. J. Photochem. Photobiol. B: (1990) 6:13–27.
- SCHMIDT-ERFURTH U, MILLER JVV, SICKENBERG M et al.: Photodynamic therapy with verteporfln for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a Phase 1 and 2 study. Arch. Ophthalmol. (1999) 117:1177–1187
- FAN KF, HOPPER C, SPEIGHT PM, BUONACCORSI GA, BOWN SG: Photodynamic therapy using m-THPC for malignant disease on the oral cavity. Int. J. Cancer (1997)73:25–32
- BONNETT R: Photosensitisers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem. Soc. Rev. (1995) 24:19–33.
- MANG TS, ALLISON R, HEWSON G, SNIDER W, MOSKOWITZ R: A Phase II/III clinical study of tin ethyl etiopurpurin (Purlytin) -induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J. Sci. Am. (1998) 4:378–84
- ROBERTS WG, SHIAU FY, NELSON JS, SMITH KM, BERNS MW: In vitro characterisation of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy. J. Natl. Cancer Inst. (1988) 80:330–336.
- GRIFFITHS J, SCHOFIELD J, WAINWRIGHT M, BROWN SB: Some observations on the synthesis of polysubstituted phthalocyanine sensitisers for photodynamic therapy. Dyes and Pigments (1997) 33:65–78.
- WOODBURN KW, FAN Q, KESSEL D: Phototherapy of cancer and atheromatous plaque with texaphyrins. J. Clin. Laser Med. Sorg. (1996) 14:343–348
- KENNEDY JC, POTTIER RH: Endogenous protopor-phyrin IX, a clinically useful photosensitiser for photodynamic therapy. J Photochem Photobiol B (1990) 14:145–148.
- CAIRNDUFF F, STRINGER MR, HUDSON EJ, ASH DV, BROWN SB: Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial and secondary skin cancer. Br. J. Cancer (1994) 69:605–608.
- ACKROYD R, BROWN N, VERNON D et al.: 5-Aminolaevulinic acid photosensitization of dysplastic Barrett's oesophagus: a pharmacokinetic study. Photochem. PhotobioL (1999) 70:656–662..
- GANNON MJ, JOHNSON N, ROBERTS DJH et al.: Photosensitisation of the endometrium with topical 5-aminolaevulininc acid. Am. J. ObsteL Gynaecol. (1995) 175:1826–1829.
- GAULLIER JM, BERG K, PENG Q et al.: Use of5-aminolevulinic acid esters to improve photody-namic therapy on cells in culture. Cancer Res. (1997) 57:1481–1486.